Published in Clin Immunol Immunopathol on March 01, 1990
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol (2011) 2.55
Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med (1997) 1.61
A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med (1997) 1.40
Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol (2000) 1.32
Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis. Am J Pathol (2004) 0.93
Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis. Am J Pathol (2003) 0.87
Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med (1978) 3.46
A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature (1994) 2.30
Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med (1986) 2.29
Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol (1997) 2.15
The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med (2001) 1.86
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res (1999) 1.85
Bone marrow derived elements and resident microglia in brain inflammation. Glia (1993) 1.78
CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol (2001) 1.76
The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol (2002) 1.75
Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest (1994) 1.63
New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J Immunol (1998) 1.58
Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol (1983) 1.58
The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia (1995) 1.55
Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest (1993) 1.53
Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J Immunol (1985) 1.51
A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol (1994) 1.47
Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med (1987) 1.41
bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development (1994) 1.40
Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement. J Immunol (1986) 1.40
Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol (1988) 1.39
Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo. Immunol Rev (1986) 1.36
Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs. J Clin Invest (1981) 1.35
Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol (1997) 1.31
Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res (2000) 1.30
Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol (2001) 1.29
Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology (1984) 1.28
Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect Immun (2001) 1.28
Spontaneous interstitial nephritis in kdkd mice. I. An experimental model of autoimmune renal disease. J Immunol (1984) 1.27
Endosomes and Golgi vesicles in adsorptive and fluid phase endocytosis. J Cell Biol (1984) 1.26
Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation (1987) 1.24
Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev (1997) 1.24
Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers. J Exp Med (1982) 1.22
Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR Am J Roentgenol (1988) 1.22
Immunology of multiple sclerosis. Clin Neurosci (1994) 1.19
T cell subsets and graft-versus-host disease. Transplantation (1987) 1.19
Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens. Am J Pathol (1997) 1.19
Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity (1993) 1.18
Microglial activation and neuronal apoptosis in Bornavirus infected neonatal Lewis rats. Brain Pathol (2000) 1.16
A computer screening approach to immunoglobulin superfamily structures and interactions: discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics. Proc Natl Acad Sci U S A (1997) 1.11
Traffic of hematogenous cells through the central nervous system. Curr Top Microbiol Immunol (1995) 1.11
Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J Neuroimmunol (1991) 1.10
Microglial cells are a component of the perivascular glia limitans. J Neurosci Res (1991) 1.09
Disseminated Candida glabrata: report of a uniquely severe infection and a literature review. Am J Clin Pathol (1983) 1.08
Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol (1992) 1.08
Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev (1983) 1.08
Rapid response of identified resident endoneurial macrophages to nerve injury. Am J Pathol (2001) 1.07
Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex. J Exp Med (1980) 1.06
Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J Comp Neurol (1997) 1.06
Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am J Pathol (2000) 1.06
Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J Immunol (1998) 1.05
Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur J Immunol (1999) 1.05
Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus. J Immunol (1983) 1.04
Candidal infection in the central nervous system. Am J Med (1984) 1.02
Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc Natl Acad Sci U S A (1995) 1.02
Malignant mesothelioma: ultrastructural distinction from adenocarcinoma. Am J Surg Pathol (1982) 1.00
Differential susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis among BALB/c substrains. Cell Immunol (1987) 1.00
Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells. Am J Pathol (1991) 1.00
Development and characterization of an experimental model of brain abscess in the rat. Am J Pathol (1992) 0.99
Spontaneous interstitial nephritis in kdkd mice. II. Characterization of a tubular antigen-specific, H-2K-restricted Lyt-2+ effector T cell that mediates destructive tubulointerstitial injury. J Immunol (1986) 0.99
Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol (1996) 0.98
Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate. Biol Blood Marrow Transplant (2001) 0.98
Acute experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice. Immunogenetics (1986) 0.97
Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann Neurol (1989) 0.97
Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol (1985) 0.97
T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Transplantation (1994) 0.97
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. J Immunol (1996) 0.97
Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat. J Immunol (1994) 0.97
Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity (1993) 0.97
Growth and metastasis of fresh human melanoma tissue in mice with severe combined immunodeficiency. Cancer Res (1991) 0.96
Experimental allergic orchitis in mice. V. Resistance to actively induced disease in BALB/cJ substrain mice is mediated by CD4+ T cells. Immunogenetics (1990) 0.96
Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci U S A (1987) 0.95
Unusual CT patterns of multiple sclerosis. AJNR Am J Neuroradiol (1983) 0.94
Human teratomas express differentiated neural antigens. An immunohistochemical study with anti-neurofilament, anti-glial filament, and anti-myelin basic protein monoclonal antibodies. Am J Pathol (1984) 0.94
Radiation bone marrow chimeras as a tool to study microglia turnover in normal brain and inflammation. Clin Neuropathol (1993) 0.93
Characteristics of poxvirus-induced meningitis: virus-specific and non-specific cytotoxic effectors in the inflammatory exudate. Scand J Immunol (1983) 0.93
Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease. J Invest Dermatol (1996) 0.92
Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease. J Invest Dermatol (1994) 0.92
Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood (2000) 0.91
Evolution of the immune response in the central nervous system following infection with Borna disease virus. J Neuroimmunol (1998) 0.91
Synthetic peptides derived from the fourth domain of CD4 antagonize off function and inhibit T cell activation. Biochem Biophys Res Commun (1996) 0.90
Immunohistochemical application of monoclonal antibodies against myelin basic protein and neurofilament triple protein subunits: advantages over antisera and technical limitations. J Histochem Cytochem (1983) 0.90
Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat Struct Biol (1996) 0.90
CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design. Immunol Today (1998) 0.89
Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol (1992) 0.89
Novel major histocompatibility complex expression by microglia and site-specific experimental allergic encephalomyelitis lesions in the rat central nervous system after optic nerve transection. Adv Neurol (1993) 0.89
Suppressor T-lymphocytes in the spinal cord of Lewis rats recovered from acute experimental allergic encephalomyelitis. Cell Immunol (1984) 0.89
Lethal graft-versus-host disease across minor histocompatibility barriers in mice. Clin Haematol (1983) 0.88
Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease. J Immunol (1998) 0.88
A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice. J Immunol (1998) 0.88
Co-localization of multiple antigens and specific DNA. A novel method using methyl methacrylate-embedded semithin serial sections and catalyzed reporter deposition. Am J Pathol (2000) 0.87
Expression of major histocompatibility complex antigens on inflammatory peripheral nerve lesions. J Neuroimmunol (1990) 0.87